EquityZen Growth Technology Fund LLC - Series 1829
Raised
$131K
Investors
11
Min Invest
$3,077
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1829 is a Delaware pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett on January 18, 2024. The fund raised $131K from 11 investors under Rule 506(b) and 3(c)(1) exemptions, with a $3K minimum investment. This is one of approximately 150 related entities managed through the EquityZen private equity platform.
This vehicle represents a typical single-series SPV structure within the private equity marketplace, using the standard 506(b)/3(c)(1) exemption combination for private placement. The $3K minimum investment is significantly lower than traditional private equity funds, consistent with platform-enabled access models that democratize exposure to growth-stage technology companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
